Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness
Adopting Foresight (OECD, 2021) can provide early warnings of challenges and opportunities, as well as the ability to study the present big picture
The synthesis technology of L-carnitine in the present invention is : It is started from S-epichlorohydrin, which is firstly used to produce a L-quaternary ammonium salt (L-chloro-3-chloro-2-hydroxypropyl trimethylamine) by the amination of trimethylamine hydrochloride, the quaternary ammonium salt is then cyanided with NaCN to produce a L-cyanide (L-chloro-3-cyan-2-hydroxypropyl trimethylamine), the cyanide is then hydrolyzed with concentrated hydrochloric acid to produce L-carnitine hydrochloride, the L-carnitine hydrochloride is finally used to produce L-carnitine product by electrodialysis desalination, concentration and refine
Third, translational gaps between preclinical models and clinical practice are prominent: most therapeutic candidates (e.g., natural products and repurposed drugs) have only been validated in rodent models, with limited data on human renal tissue responses, optimal dosing windows, or potential drugdrug interactions in clinical settings (e.g., in patients undergoing kidney transplantation or cardiovascular surgery)
Research advances and prospects on mechanism of Sinomenin on histamine release and the binding to histamine receptors
Hormone Research, 51 (2), 78-84
.png)
